12:00 AM
 | 
Apr 12, 2010
 |  BC Week In Review  |  Clinical News  |  Regulatory

Tesetaxel regulatory update

FDA granted Fast Track designation to tesetaxel to treat advanced gastric cancer in patients who failed a platinum and fluoropyrimidine-containing...

Read the full 80 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >